Please login to the form below

Not currently logged in
Email:
Password:

pharma

This page shows the latest pharma news and features for those working in and with pharma, biotech and healthcare.

Sanofi sells European generics to Advent for $2.4bn

Sanofi sells European generics to Advent for $2.4bn

Private equity group Advent has agreed a 1.9bn ($2.4bn) deal to buy the European generics unit of French pharma company Sanofi. ... The deal comes as a number of other big pharma companies have decided to narrow their focus, bulking up in core areas and

Latest news

More from news
Approximately 664 fully matching, plus 1,511 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    general negativity around pharma pricing - could mean a backward step for innovation. ... What is realistic? What would incentivise pharma? Get involved in the debate on.

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    While a new army of smaller biotechs is focusing on AMR innovation, to truly drive research forward and strengthen the dwindling global pipeline, big pharma must be encouraged to remain in - ... For biotechs, pharma companies and their investors, there

  • Brexit Means Brexit Brexit Means Brexit

    We see this in the trade body positions and we also see it internally within pharma organisations. ... Yet despite the enormity of what is at stake, pharma must remain pragmatic and flexible.

  • Beyond caring: learning from the unsung advocates in cancer care

    However despite this, carers are an often underappreciated stakeholder in what pharma calls the ‘treatment journey’. ... For many years pharma and clinicians have, rightly, focused on putting the patient at the heart of their activities.

  • A new era of smart pharma A new era of smart pharma

    A new era of smart pharma. How smarter pharmaceuticals and pharmacovigilance are transforming healthcare. ... Pharma companies are having to adapt and innovate to keep pace with the vast changes brought about by digital technology.

More from intelligence
Approximately 125 fully matching, plus 479 partially matching documents found.

Latest appointments

  • Sobi poaches Pfizer’s Fredrick Wetterlundh Sobi poaches Pfizer’s Fredrick Wetterlundh

    Joining from pharma giant Pfizer, Wetterlundh most recently held the position of global human resources lead, gaining extensive experience in leading business-driven HR organisations, processes and projects in Asia, Europe,

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Neurocentrx appoints two members to the board. Nigel Brooksby and Dr Tim Corn join the pharma group. ... Joining Brooksby is EUSA Pharma’s former chief medical officer Dr Tim Corn, who becomes the pharma group’s non-executive director.

  • Novo Nordisk appoints new general manager Novo Nordisk appoints new general manager

    Danish pharma group Novo Nordisk has appointed a new general manager and corporate vice president, UK, in the form of Pinder Sahota.

  • David Colpman joins Forendo Pharma’s board David Colpman joins Forendo Pharma’s board

    David Colpman joins Forendo Pharma’ s board. He becomes a non-executive director. ... Forendo Pharma, a drug development company, has appointed David Colpman to its board of directors.

  • Hansa Medical poaches Vifor Pharma’s CEO Hansa Medical poaches Vifor Pharma’s CEO

    Hansa Medical poaches Vifor Pharma’ s CEO. Søren Tulstrup becomes the Swedish biopharma’s CEO and president. ... Additionally, Tulstrup has served as CEO of Santaris Pharma, now part of Roche, and in several senior commercial roles within Merck &Co

More from appointments
Approximately 70 fully matching, plus 508 partially matching documents found.

Latest from PMHub

  • Random42 honoured with Queen’s Award for Enterprise

    We are positioned to grow rapidly over the next five years and beyond, being a world-leader in science education, both from a pharma perspective, but also the broader research community.”.

  • Random42 Named in Alantra’s Pharma Fast 50.

    Businesses are selected for their rapid revenue growth over the past two years and are very often found to be working closely with big pharma. ... For more on the Pharma Fast 50 read the full article: . For further information please contact - Random42

  • How to find pharma content that inspires your audience

    How to find pharma content that inspires your audience. Getting your customers’ attention begins with presenting pharma content that speaks to their needs and wants effectively. ... When it comes to pharma content, however, it’ s time for you to take

  • White paper download: Increase reach and engagement with multichannel marketing

    White paper download: Increase reach and engagement with multichannel marketing. Download our white paper "Multichannel marketing for pharma" to learn how to implement MCM strategies effectively. ... Download our  Multichannel Marketing for Pharma White

  • Personalizing customer engagement in pharma

    Includes commentary on customer engagement in pharma and next step in multichannel marketing. ... Summary/transcript. Barcelona eyeforpharma 2015 highlights: Philippe Kirby, Merck, David Hunt, Havas LYNX, and Richie Bavasso, Agnitio share their views on

More from PMHub
Approximately 199 fully matching, plus 663 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics